CORONA Pfizer CEO says COVID-19 pill could be ready by end of the year

TerryK

TB Fanatic
Looks like it's already developed and in testing.
They started clinical trials , in March.
This drug is to treat people who have already been infected with Covid.
The drug blocks an enzyme that allows the Corona virus to make copies of itself.
Protease inhibitors are already used in drugs we use today.
They also say the drug should be effective against all variants and possibly some other types of Corona virus.

Coronavirus: Pfizer CEO says COVID-19 pill could be ready by end of the year

April 28, 2021 at 1:25 pm CDTBy Debbie Lord, Cox Media Group National Content Desk

Officials at the pharmaceutical company Pfizer say they expect that a pill that treats COVID-19 will be available to the public by the end of the year.

Albert Bourla, the company’s CEO, said Tuesday he expected the experimental oral drug would be effective against multiple variants of the virus. The drug, Bourla said, would be used to treat those with the virus at the onset of symptoms in hopes that it would keep people from having to go to the hospital for treatment.


Pfizer was the first company to gain the Food and Drug Administration’s Emergency Use Authorization for a COVID-19 vaccine. More than 122 million people have received the Pfizer vaccine.

The new drug is a protease inhibitor, or a drug that fights a virus by blocking an enzyme that the virus needs to make copies of itself in human cells.

Clinical trials on the drug began in March, according to CNBC. Trials will have to be completed with results submitted to the FDA for approval for use.

The drug would be combined with a dose of Ritonavir, an antiviral, to boost the effectiveness of the drug, according to a story in the Telegraph.

“If they have moved to this stage, they will be quietly optimistic,” said Penny Ward, who is the visiting professor in pharmaceutical medicine at King’s College London and a pioneer in the development of Tamiflu, an antiviral that combats seasonal and pandemic flu.

“The question will be about how the drug is tolerated,” Ward told the Telegraph.

Pfizer reported the progress on the drug in a news release last month.

“The oral antiviral clinical candidate PF-07321332, a SARS-CoV2-3CL protease inhibitor, has demonstrated potent in vitro antiviral activity against SARS-CoV-2, as well as activity against other coronaviruses, suggesting potential for use in the treatment of COVID-19 as well as potential use to address future coronavirus threats,” the company said in a press release.
 
Last edited:

TerryK

TB Fanatic
They haven't even isolated the virus. How the heck?
Where do you get that kind of false information. It's not true.
How in the hell do you think they developed the complete gene map of the virus.
Any reputable medical research facility can get samples of the virus grown in medium for various research purposes.

Jeez read below and stop parroting a lot of the info circulating on alt media.
The US had isolated and was culturing the Covid 19 virus over a year ago. January 2020 to be exact and in Feb 2020 they had enough to offer sample to various research facilities that met minimum safety requirements.

Do you have any idea how frustrating it is to constantly have to correct people who believe the crazy shit put out by some of the alt meda and a few of the more gullible members here.



SARS-CoV-2 Viral Culturing at CDC
Updated Dec. 29, 2020
Print
SARS-CoV-2, the virus that causes COVID-19, was isolated in the laboratory and is available for research by the scientific and medical community.
One important way that CDC has supported global efforts to study and learn about SARS-CoV-2 in the laboratory was by growing the virus in cell culture and ensuring that it was widely available. Researchers in the scientific and medical community can use virus obtained from this work in their studies.
CDC is using SARS-CoV-2 in various ways, including the following:
SARS-CoV-2 strains supplied by CDC and other researchers can be requested, free, from the Biodefense and Emerging Infections Research (BEI) Resources Repositoryexternal icon by established institutions that meet BEI requirements. These requirements include maintaining appropriate facilities and safety programs, as well as having the appropriate expertise. BEI supplies organisms and reagents to the broader community of microbiology and infectious disease researchers.

Some areas of COVID-19 research that public and academic institutions may study with the SARS-CoV-2 strains include:

  • Antiviral research:external icon This includes research aimed at testing the ability of existing or experimental antiviral medications to treat or prevent infection with SARS-CoV-2.
  • Vaccine development:external icon Scientists in public, private sector, and academic institutions continue to work together to develop safe and effective COVID-19 vaccines. Learn more about currently authorized vaccines in the United States.
  • Pathogenesis research: This includes research to determine the various ways the virus can be transmitted to a host, the severity of illness it causes in a host, how much virus is produced in the body, and what organs the virus can spread to within the body.
  • Virus stability research:external icon This is research that indicates how long the virus can survive under certain conditions, such as how long the virus can survive and remain infectious on surfaces, and the temperatures at which it can survive.
Timeline:

  • On January 20, 2020, CDC received a clinical specimen collected from the first reported U.S. patient infected with SARS-CoV-2. CDC immediately placed the specimen into cell culture to grow a sufficient amount of virus for study.
  • On February 2, 2020, CDC generated enough SARS-CoV-2 grown in cell culture to distribute to medical and scientific researchers.
  • On February 4, 2020, CDC shipped SARS-CoV-2 to the BEI Resources Repository.
  • An article discussing the isolation and characterization of this virus specimen is available in Emerging Infectious Diseases.
 

kyrsyan

Has No Life - Lives on TB
Where do you get that kind of false information. It's not true.
How in the hell do you think they developed the complete gene map of the virus.
Any reputable medical research facility can get samples of the virus grown in medium for various research purposes.

Jeez read below and stop parroting a lot of the info circulating on alt media.
The US had isolated and was culturing the Covid 19 virus over a year ago. January 2020 to be exact and in Feb 2020 they had enough to offer sample to various research facilities that met minimum safety requirements.

Do you have any idea how frustrating it is to constantly have to correct people who believe the crazy shit put out by some of the alt meda and a few of the more gullible members here.



SARS-CoV-2 Viral Culturing at CDC
Updated Dec. 29, 2020
Print
SARS-CoV-2, the virus that causes COVID-19, was isolated in the laboratory and is available for research by the scientific and medical community.
One important way that CDC has supported global efforts to study and learn about SARS-CoV-2 in the laboratory was by growing the virus in cell culture and ensuring that it was widely available. Researchers in the scientific and medical community can use virus obtained from this work in their studies.
CDC is using SARS-CoV-2 in various ways, including the following:
SARS-CoV-2 strains supplied by CDC and other researchers can be requested, free, from the Biodefense and Emerging Infections Research (BEI) Resources Repositoryexternal icon by established institutions that meet BEI requirements. These requirements include maintaining appropriate facilities and safety programs, as well as having the appropriate expertise. BEI supplies organisms and reagents to the broader community of microbiology and infectious disease researchers.

Some areas of COVID-19 research that public and academic institutions may study with the SARS-CoV-2 strains include:

  • Antiviral research:external icon This includes research aimed at testing the ability of existing or experimental antiviral medications to treat or prevent infection with SARS-CoV-2.
  • Vaccine development:external icon Scientists in public, private sector, and academic institutions continue to work together to develop safe and effective COVID-19 vaccines. Learn more about currently authorized vaccines in the United States.
  • Pathogenesis research: This includes research to determine the various ways the virus can be transmitted to a host, the severity of illness it causes in a host, how much virus is produced in the body, and what organs the virus can spread to within the body.
  • Virus stability research:external icon This is research that indicates how long the virus can survive under certain conditions, such as how long the virus can survive and remain infectious on surfaces, and the temperatures at which it can survive.
Timeline:

  • On January 20, 2020, CDC received a clinical specimen collected from the first reported U.S. patient infected with SARS-CoV-2. CDC immediately placed the specimen into cell culture to grow a sufficient amount of virus for study.
  • On February 2, 2020, CDC generated enough SARS-CoV-2 grown in cell culture to distribute to medical and scientific researchers.
  • On February 4, 2020, CDC shipped SARS-CoV-2 to the BEI Resources Repository.
  • An article discussing the isolation and characterization of this virus specimen is available in Emerging Infectious Diseases.
Oh, yes, they have indeed isolated SARS-CoV-2. No argument there. They have not isolated COVID-19. So while the pill may work for SARS-CoV-2, there is no way of being sure that it will work for COVID-19.
 

TammyinWI

Talk is cheap
HCQ and Ivermectin are ready now.

These people are power-tripping and purposely killing people, including forcing people with pre-existing conditions to be over-treated and probably poisoned, who knows what, when they get sick with Influenza A or B, and then they are reported as having covid, forced on ventilators, because the med. staff want to keep their jobs and get paid for each "covid" patient.

It is a killing machine!

In the meantime, normal sneezing and coughing, or runny sinuses, allergies, like every year, is normal, but suspect!
 

PrairieMoon

Veteran Member
Oh, yes, they have indeed isolated SARS-CoV-2. No argument there. They have not isolated COVID-19. So while the pill may work for SARS-CoV-2, there is no way of being sure that it will work for COVID-19.

Covid-19 is the disease caused by SARS-Cov-2, the virus. It’s real. Both the virus and the disease are real.
 

Krayola

Veteran Member
Oh, yes, they have indeed isolated SARS-CoV-2. No argument there. They have not isolated COVID-19. So while the pill may work for SARS-CoV-2, there is no way of being sure that it will work for COVID-19.
SARS-CoV-2 is the virus that causes Covid-19.

If the pill works on SARS-CoV-2, then obviously it works on the virus caused by SARS-CoV-2. Are you claiming that Covid-19 is actually caused by a different virus?
 

kyrsyan

Has No Life - Lives on TB
My apologies. I've been researching the prior versions of the virus and got things mixed up in my head with the versions.
A friend and I have been discussing that there is actually a successful real vaccine for a prior version. Both of us are willing to try a vaccine created by the same company/group that created that vaccine.
But I still doubt the success of the medicine until they can isolate and propagate the wild virus, not the laboratory sample.
 

philkar

Veteran Member
The wrong question is being asked! The REAL question should be are you, Mr. CEO, going to take the pill like you took the vax? Oh wait. You didn't take the vax. Well here is your second chance.
 

Double_A

TB Fanatic
My apologies. I've been researching the prior versions of the virus and got things mixed up in my head with the versions.
A friend and I have been discussing that there is actually a successful real vaccine for a prior version. Both of us are willing to try a vaccine created by the same company/group that created that vaccine.
But I still doubt the success of the medicine until they can isolate and propagate the wild virus, not the laboratory sample.

I dont understand you, where did the Lab sample come from, if not from the "wild" virus as you call it?
 
Top